PMCF Study on the Safety, Performance and Clinical Benefits Data of the Anatomical Shoulder 2.0 Fracture System
A legfontosabb adatok
- Ki végzi
- Zimmer Biomet
- Hol
- Salamanca (Spanyolország)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 78 fő, tervezett
- Kezdés
- 2022. júl. 7.
- Várható befejezés
- 2034. jan. 21.
- A vizsgálat típusa
- Megfigyeléses
- A regiszteradat frissítve
- 2025. augusztus 17.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults who had a shoulder replacement with the Anatomical Shoulder 2.0 Fracture System after a fracture of the upper arm bone or its later damage.
- Életkor
- 18 years or older, with a fully grown skeleton.
- Nem
- All sexes can join.
- A betegség stádiuma
- Complex 3- and 4-part fractures of the upper end of the arm bone (proximal humerus), an unstable fracture after earlier fixing, or bone death (necrosis) or joint wear (arthrosis) of the humeral head after an injury.
- Korábbi kezelés
- People must have had a total, partial (hemi) or fracture shoulder replacement with this system.
A részvétel fő kizáró okai
- Pregnant or breastfeeding
- Signs of infection
- Strong stiffening of the shoulder joint without pain
- Vulnerable people, such as prisoners, people who cannot understand the study, or known alcohol or drug abusers
- Unable or unwilling to consent or come to follow-up visits, or plans to move away
A regiszter feltételei, szó szerint
Mind a 10 feltétel megnézéseKevesebb
Ki vehet részt
- Patients 18 years or older and skeletally mature
- Patients capable of understanding the surgeon's explanations and following his instructions, able and willing to participate in the follow-up program and who gave consent to take part in the study
- Replacement of the proximal humerus and the glenoid articular surface of the scapula during total-, hemi- and fracture shoulder arthroplasty in treatment of the following:; Complex 3- and 4- part fractures of the proximal humerus with subluxation of the head fragment; Complex 3- and 4- part fractures of the proximal humerus with loosening of the spongiosa in the head fragment; Complex 3- and 4- part fractures of the proximal humerus with additional cross split of the head fragment; Fracture instability after osteosynthesis of 3- and 4-part fracture fragments of the proximal humerus; Posttraumatic necrosis of the humeral head; Posttraumatic arthrosis after humeral head fracture
Ki nem vehet részt
- Patient is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, anticipated to be non-compliant)
- Patients who have any condition that would in the judgment of the Investigator place the patient at undue risk or interfere with the study
- Signs of infection
- Patients who are unwilling or unable to give consent, not willing to return for study required follow-up visits and/or to comply with the follow-up program
- The patient is known to be pregnant or breastfeeding
- Patients with plans to relocate during the study follow-up period
- Extensive stiffening of the shoulder joint without pain
Ez a vizsgálat jelenleg itt érhető el: Spanyolország.
- Salamenca University HospitalSalamanca, SpanyolországContact: Alberto Moreno, DrRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The study is a multicenter, retrospective and prospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to collect long-term data confirming safety, performance and clinical benefits of the Anatomical Shoulder 2.0 Fracture System (Implants and Instrumentation) when used for fracture shoulder arthroplasty. The primary objective is the assessment of safety by analyzing implant survivorship. This will be established by recording the incidence and frequency of revisions, complications and adverse events. Relation of the events to implant, instrumentation and/or procedure should be specified.
A teljes eredeti leírásKevesebb
The secondary objective is the assessment of performance and clinical benefits by recording patient-reported clinical outcome measures (PROMs) as well as radiographic outcomes.
A vizsgálat csoportja
- Patients who received the Anatomical Shoulder 2.0 Fracture
Anatomical Shoulder 2.0 Fracture
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the Anatomical Shoulderᵀᴹ 2.0 Fracture System (Implants and Instrumentation) - A Retrospective and Prospective Consecutive Series Study
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2025. augusztus 17.